福善美是这类药物的第一个上市药品，1995年由默克公司生产上市。

The first such drug, Fosamax, was marketed by Merck in 1995.

youdao

许多药物治疗可以有助于减缓骨质流失和保持骨量，其中包括二膦酸盐(福善美、Actonel、Boniva)和雷洛昔芬(Evista)。

A number of medications are available to help slow bone loss and maintain bone mass, including bisphosphonates (Fosamax, Actonel, Boniva) and raloxifene (Evista).

youdao

在美国的一项研究中，科学家发现，服用福善美或其他双磷酸盐口服药的女性，其乳腺癌患者数比没有服药的女性中乳腺癌患者数少31%。

In one U. S. study, scientists found there were 31 percent fewercases of breast cancer among women who took Fosamax or other oralbisphosphonates than among women who didn't.

youdao

在美国的一项研究中，科学家发现，服用福善美或其他双磷酸盐口服药的女性，其乳腺癌患者数比没有服药的女性中乳腺癌患者数少31%。

In one U. S. study, scientists found there were 31 percent fewercases of breast cancer among women who took Fosamax or other oralbisphosphonates than among women who didn't.

youdao